EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 11.75p on 14-01-2026 at 19:20:08 |
|---|---|
| Change | 0.50p 4.44% |
| Buy | 12.00p |
| Sell | 11.50p |
| Last Trade: | Sell 10,000.00 at 11.70p |
| Day's Volume: | 3,427,579 |
| Last Close: | 11.75p |
| Open: | 11.25p |
| ISIN: | GB00BYV81293 |
| Day's Range | 11.25p - 11.75p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £125.47m |
| VWAP: | 11.6704p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,000 | 11.70p | Ordinary |
16:27:47 - 14-Jan-26 |
| Sell* | 1,103 | 11.70p | Ordinary |
16:26:18 - 14-Jan-26 |
| Sell* | 100,000 | 11.67p | Ordinary |
16:22:27 - 14-Jan-26 |
| Sell* | 4,000 | 11.67p | Ordinary |
16:07:35 - 14-Jan-26 |
| Sell* | 4,328 | 11.67p | Ordinary |
16:02:27 - 14-Jan-26 |
| Sell* | 12,854 | 11.67p | Ordinary |
15:59:15 - 14-Jan-26 |
| Sell* | 10,638 | 11.67p | Ordinary |
15:58:51 - 14-Jan-26 |
| Buy* | 738 | 11.9448p | Ordinary |
15:50:22 - 14-Jan-26 |
| Sell* | 3,000 | 11.675p | Ordinary |
15:41:39 - 14-Jan-26 |
| Buy* | 84,460 | 11.84p | Ordinary |
15:33:29 - 14-Jan-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Jan 2026 11:06 am | RNS | Block listing 6 Monthly Return |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 18th Dec 2025 7:13 am | RNS | Block Listing Application |
| 11th Dec 2025 7:00 am | RNS-R | Shield Wins Gold at Titan Branding Awards |
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |